Specific serology for emerging human coronaviruses by protein microarray.

We present a serological assay for the specific detection of IgM and IgG antibodies against the emerging human coronavirus hCoV-EMC and the SARS-CoV based on protein microarray technology. The assay uses the S1 receptor-binding subunit of the spike protein of hCoV-EMC and SARS-CoV as antigens. The assay has been validated extensively using putative cross-reacting sera of patient cohorts exposed to the four common hCoVs and sera from convalescent patients infected with hCoV-EMC or SARS-CoV.

[1]  C. Macintyre,et al.  The discrepant epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) , 2014, Environment Systems and Decisions.

[2]  D. Butler.  Novel bird flu kills two in China , 2013, Nature.

[3]  Christian Drosten,et al.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.

[4]  U. Buchholz,et al.  Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  Daniel S. Chertow,et al.  Bacterial coinfection in influenza: a grand rounds review. , 2013, JAMA.

[6]  T. Wolff,et al.  Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  H. Zeller,et al.  Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  C. Sousa,et al.  Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  Z. Memish,et al.  Recovery from severe novel coronavirus infection. , 2012, Saudi medical journal.

[10]  Alexander E. Gorbalenya,et al.  Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans , 2012, mBio.

[11]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[12]  Monica Lahra,et al.  The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance. , 2012, Sexual health.

[13]  B. Cowling,et al.  Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  R. Pebody,et al.  Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  R. Pebody,et al.  The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  T. Bestebroer,et al.  Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  M. Koopmans,et al.  Profiling of humoral immune responses to influenza viruses by using protein microarray. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  Josefina Ayats,et al.  Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. , 2012, The Journal of antimicrobial chemotherapy.

[19]  D. Whiley,et al.  Improved detection of genetic markers of antimicrobial resistance by hybridization probe-based melting curve analysis using primers to mask proximal mutations: examples include the influenza H275Y substitution. , 2012, The Journal of antimicrobial chemotherapy.

[20]  M. Ohnishi,et al.  Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. , 2012, The Journal of antimicrobial chemotherapy.

[21]  T. Kuijpers,et al.  The dominance of human coronavirus OC43 and NL63 infections in infants , 2011, Journal of Clinical Virology.

[22]  M. Unemo,et al.  High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure , 2011, Antimicrobial Agents and Chemotherapy.

[23]  M. Unemo,et al.  Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone , 2011, Antimicrobial Agents and Chemotherapy.

[24]  Magnus Unemo,et al.  Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. , 2010, Biochemistry.

[25]  N. Shaikh,et al.  Prevalence of Streptococcal Pharyngitis and Streptococcal Carriage in Children: A Meta-analysis , 2010, Pediatrics.

[26]  Haruo Watanabe,et al.  Spread of a Chromosomal Cefixime-Resistant penA Gene among Different Neisseria gonorrhoeae Lineages , 2009, Antimicrobial Agents and Chemotherapy.

[27]  John W Tapsall,et al.  Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins , 2009, Current opinion in infectious diseases.

[28]  B. Henriques-Normark,et al.  Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe , 2009, Journal of Clinical Microbiology.

[29]  E. Severance,et al.  Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population , 2008, Clinical and Vaccine Immunology.

[30]  J. McCullers.  Planning for an influenza pandemic: thinking beyond the virus. , 2008, The Journal of infectious diseases.

[31]  K. Pyrć,et al.  Human Coronavirus NL63 and 229E Seroconversion in Children , 2008, Journal of Clinical Microbiology.

[32]  B. Henriques-Normark,et al.  Epidemiology of Severe Streptococcus pyogenes Disease in Europe , 2008, Journal of Clinical Microbiology.

[33]  D. Whiley,et al.  A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. , 2008, Diagnostic microbiology and infectious disease.

[34]  M. Yasuda,et al.  Rapid Detection of the Mosaic Structure of the Neisseria gonorrhoeae penA Gene, Which Is Associated with Decreased Susceptibilities to Oral Cephalosporins , 2008, Journal of Clinical Microbiology.

[35]  C. Sousa,et al.  Vector monitoring of Aedes aegypti in the Autonomous Region of Madeira, Portugal. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  A. Sandgren,et al.  Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  John W. Tapsall,et al.  Diversity of penA Alterations and Subtypes in Neisseria gonorrhoeae Strains from Sydney, Australia, That Are Less Susceptible to Ceftriaxone , 2007, Antimicrobial Agents and Chemotherapy.

[38]  Takashi Ida,et al.  Amino Acid Substitutions in Mosaic Penicillin-Binding Protein 2 Associated with Reduced Susceptibility to Cefixime in Clinical Isolates of Neisseria gonorrhoeae , 2006, Antimicrobial Agents and Chemotherapy.

[39]  E. Wald,et al.  Group A Streptococci Among School-Aged Children: Clinical Characteristics and the Carrier State , 2004, Pediatrics.

[40]  Zuyuan Xu,et al.  Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. , 2004, Journal of medical microbiology.

[41]  E. Liu,et al.  Detection of Severe Acute Respiratory Syndrome Coronavirus in Blood of Infected Patients , 2004, Journal of Clinical Microbiology.

[42]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[43]  K. O'Brien,et al.  Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  Dwight R. Johnson,et al.  Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis , 2001, The Lancet.

[45]  A. Efstratiou,et al.  Group A streptococci in the 1990s. , 2000, The Journal of antimicrobial chemotherapy.

[46]  A. W. Kemp,et al.  Randomization, Bootstrap and Monte Carlo Methods in Biology , 1997 .

[47]  R. Facklam,et al.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci , 1996, Journal of clinical microbiology.

[48]  L. Burman,et al.  Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. , 1991, The Journal of infectious diseases.

[49]  E. Kaplan.  The resurgence of group A streptococcal infections and their sequelae , 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[50]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[51]  Toshiyuki Yamamoto,et al.  CONFLICT OF INTEREST: None declared. , 2013 .

[52]  Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[53]  Shane Marley,et al.  Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.